HEALTH LINE: Free Women's Health Screenings to Those Who Qualify
A community service grant called the Breast Cancer and Cervical Cancer Project, known as the BCCP project, provides thousands of Ohio women with free breast and cervical screeningsand diagnostic tests if needed.
"The purpose of this project is to increase breast and cervical cancer screenings, thereby diagnosing those diseases in the earliest stages, says Beth OConnor, a BCCP program director based at the University of Cincinnati (UC) College of Medicines department of obstetrics and gynecology.
The BCCP is funded by the Ohio Department of Health (ODH), which mandates that these services are accessible at the community level to all eligible women. The Ohio BCCP grant, funded annually at approximately $250,000, was originated in 1994 by the U.S. Centers for Disease Control and Prevention (CDC) and since 2007 has received additional funding from the state.
The UC office is responsible for administering the grant in five southwestern Ohio countiesHamilton, Butler, Warren, Clinton and Clermontand is one of 11 offices in the state responsible for implementing the program. The BCCP here, OConnor says, screens an average of 1,300 women each year, with a 55 percent re-screening rate.
Women are eligible if they live in Ohio, are 40 years of age or older, have limited income and are uninsured. Women who meet the program criteria are eligible for a free Pap test, pelvic exam, clinical breast exam and mammogram.
Women screened through the BCCP program may also be eligible for financial assistance for diagnostic tests and treatment.
About 40 percent of women enrolled in the BCCP program require additional procedures after screening, says OConnor.
Studies show that if detected early, nearly all breast and cervical cancers can be treated successfully, says OConnor.
For more information about the BCCP program or to inquire regarding qualifications please call locally at 513-584-0053, toll free at 1-888-PAP-MAMM or visit the website
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.